10x Genomics, Inc. vs Induct AS
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- 10x Genomics, Inc. is the larger company by market value: $9.4 B against $9 M for Induct AS, 1046 times as much (market caps of Oct 26, 2026 for 10x Genomics, Inc. and Jan 5, 2024 for Induct AS). Induct AS's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | 10x Genomics, Inc. TXG · #2,267 in the world | Induct AS INDCT.OL |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇳🇴 Norway |
| Sector | Healthcare | Healthcare |
| Industry | Healthcare Information Services | Healthcare Information Services |
| Founded | 2012 | — |
| Size | ||
| Market cap | $9.4 B | $9 M* |
| Revenue | $643 M | — |
| Net income | $-44 M | — |
| Employees | 1,243 | — |
| Valuation | ||
| Price to sales | 15.2× | — |
| Price to book | 11.8× | — |
| Free cash flow yield | 1.4% | — |
| Profitability | ||
| Gross margin | 69.0% | — |
| Operating margin | -9.5% | — |
| Net margin | -6.8% | — |
| Return on equity | -5.8% | — |
| Growth | ||
| Revenue growth | 5.3% | — |
| Revenue growth, 3 years a year | 7.6% | — |
| Cash | ||
| Free cash flow margin | 20.2% | — |
| Altman Z-score zone | safe | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Jan 2024 |
Questions and answers#
Which is bigger, 10x Genomics, Inc. or Induct AS?
10x Genomics, Inc. is the larger company by market value: $9.4 B against $9 M for Induct AS, 1046 times as much (market caps of Oct 26, 2026 for 10x Genomics, Inc. and Jan 5, 2024 for Induct AS). Induct AS's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.